Jeff Cislini, General Counsel at Revolution Medicines, Inc. (RVMD), sold 56,894 shares at $207.24 ($11.9M) on 2026-08-21, disclosed to the SEC on 2026-08-25.
Scheduled sale ($11.9M) by General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $207.24 | 3,400 | $705K | 5.9% |
| 2 | $208.37 | 17,323 | $3.6M | 30.3% |
| 3 | $209.25 | 25,817 | $5.4M | 45.4% |
| 4 | $210.26 | 2,540 | $534K | 4.5% |
| 5 | $211.34 | 4,500 | $951K | 8.0% |
| 6 | $212.06 | 3,314 |
| $703K |
| 5.9% |
| Total | $209.24 avg | 56,894 | $11.9M | 100% |
| Filing → |
| RVMD | SELL | 2026-06-18 | $337K | — | Filing → |
| RVMD | SELL | 2026-03-19 | $470K | — | Filing → |
| RVMD | SELL | 2026-01-23 | $105K | — | Filing → |